- Category
- Micro (2023-24)
- Udyam number
- UDYAM-RJ-17-0266726

Inspeed Formulations Private Limited
About Inspeed Formulations Private Limited
Data last updated:
Inspeed Formulations Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24304RJ2020PTC072200. Its GSTIN is 08AAFCI9064G1ZB (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ajay Arora and Vishal Arora.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 8 2nd Floor Malviya Industrial Area Malviya Nagar, Jaipur, Rajasthan, India – 302017.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.16 Cr, a decline of 36% compared to the previous year. For the same year it recorded a net profit of ₹2.39 Lakh (net margin 2.1%) and EBITDA of ₹3.19 Lakh (EBITDA margin 2.7%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years.
Inspeed Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0266726).
Company details
Recognitions & Rankings of Inspeed Formulations
Contact details
Inspeed Formulations Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB – 8 2nd Floor Malviya Industrial Area Malviya Nagar, Jaipur, Rajasthan, India – 302017
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Inspeed Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Inspeed Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Inspeed Formulations Private Limited, buy the company report.
Financials of Inspeed Formulations Private Limited
FY 2025 filings availableInspeed Formulations Private Limited reported revenue of ₹1.16 Cr (down 36% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 22% over three years, including a 36% fall in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.19 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.39 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.7% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Inspeed Formulations Private Limited, buy the company report.
Board of directors of Inspeed Formulations Private Limited
Inspeed Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ajay Arora Also directs: C.M. Arora Pharma Private Limited, Arora Medicine Private Limited | Director | 20 Nov 2020 | 5 Years 11 Months | Current |
| Vishal Arora Also directs: C.M. Arora Pharma Private Limited, Arora Medicine Private Limited | Director | 20 Nov 2020 | 5 Years 11 Months | Current |
Peer comparison
Inspeed Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pyrax Health Sciences Private Limited | ₹1.17 Cr (FY 2025) | -4.0% | Roorkee, Uttarakhand, India | |||
| Inspeed Formulations Private Limitedthis company | ₹1.16 Cr (FY 2025) | ₹2.39 Lakh | 2.1% | -36.0% | Jaipur, Rajasthan, India | |
| Credas Labs Private Limited | ₹1.16 Cr (FY 2024) | -58.0% | Hyderabad, Telangana, India | |||
| Meghnagar Pharmachem Private Limited | ₹1.16 Cr (FY 2023) | -92.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Inspeed Formulations Private Limited, buy the company report.
Auditor
Inspeed Formulations Private Limited is audited by SURESH KHANDELWAL & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURESH KHANDELWAL & COMPANY | FY 2023 | 007021C |
Shareholding
The shareholding of Inspeed Formulations Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Inspeed Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Inspeed Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Inspeed Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Inspeed Formulations Private Limited has 1 active EPFO establishment as of Apr 09, 2024.
GST
Inspeed Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAFCI9064G1ZB | Rajasthan | Active | 31 Mar 2021 |
To see the full GST registrations and return filing status of Inspeed Formulations Private Limited, buy the company report.
Recent activity
Inspeed Formulations Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Ajay Arora was appointed as Director on 20 Nov 2020.
Frequently asked questions
Inspeed Formulations is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 November 2020 (6+ years old) and is registered under CIN U24304RJ2020PTC072200.
Inspeed Formulations has 2 current directors:
- Ajay Arora - Director
- Vishal Arora - Director
The latest financial statements of Inspeed Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Inspeed Formulations is 08AAFCI9064G1ZB, registered in Rajasthan.
The CIN (Corporate Identification Number) of Inspeed Formulations is U24304RJ2020PTC072200. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Inspeed Formulations was incorporated on 20 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Inspeed Formulations by revenue are Pyrax Health Sciences Private Limited, Credas Labs Private Limited, Meghnagar Pharmachem Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ajay Arora was appointed as Director on 20 Nov 2020. Vishal Arora was appointed as Director on 20 Nov 2020.
Yes, Inspeed Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0266726).
The registered office of Inspeed Formulations is at B – 8 2nd Floor Malviya Industrial Area Malviya Nagar, Jaipur, Rajasthan, India – 302017.
Inspeed Formulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.